Hawkins, Inc. (NASDAQ:HWKN - Get Free Report)'s stock price hit a new 52-week low on Wednesday . The stock traded as low as $121.18 and last traded at $121.78, with a volume of 175742 shares changing hands. The stock had previously closed at $123.68.
Wall Street Analysts Forecast Growth
Several research firms have commented on HWKN. BWS Financial upgraded shares of Hawkins from a "neutral" rating to a "buy" rating and set a $160.00 target price for the company in a research report on Monday, April 14th. CJS Securities initiated coverage on Hawkins in a research report on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 target price on the stock.
Read Our Latest Research Report on HWKN
Hawkins Price Performance
The business's 50-day simple moving average is $111.45 and its 200 day simple moving average is $117.04. The company has a market capitalization of $2.50 billion, a P/E ratio of 30.58, a P/E/G ratio of 3.80 and a beta of 0.87. The company has a current ratio of 2.50, a quick ratio of 1.53 and a debt-to-equity ratio of 0.23.
Institutional Investors Weigh In On Hawkins
Institutional investors have recently added to or reduced their stakes in the company. Vaughan Nelson Investment Management L.P. lifted its holdings in shares of Hawkins by 37.6% in the first quarter. Vaughan Nelson Investment Management L.P. now owns 350,722 shares of the specialty chemicals company's stock valued at $37,148,000 after buying an additional 95,885 shares during the period. Wasatch Advisors LP bought a new stake in Hawkins in the fourth quarter worth about $42,466,000. Northern Trust Corp lifted its holdings in Hawkins by 16.1% in the 4th quarter. Northern Trust Corp now owns 235,096 shares of the specialty chemicals company's stock valued at $28,839,000 after acquiring an additional 32,670 shares during the last quarter. GW&K Investment Management LLC boosted its position in shares of Hawkins by 3.2% during the 1st quarter. GW&K Investment Management LLC now owns 220,327 shares of the specialty chemicals company's stock valued at $23,337,000 after purchasing an additional 6,832 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Hawkins by 61.9% in the 4th quarter. JPMorgan Chase & Co. now owns 149,616 shares of the specialty chemicals company's stock worth $18,353,000 after purchasing an additional 57,179 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors and hedge funds.
Hawkins Company Profile
(
Get Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Read More
Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.